Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Pollut Bull ; 200: 116157, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38364643

ABSTRACT

The Blue Growth strategy promises a sustainable use of marine resources for the benefit of the society. However, oil pollution in the marine environment is still a serious issue for human, animal, and environmental health; in addition, it deprives citizens of the potential economic and recreational advantages in the affected areas. Bioremediation, that is the use of bio-resources for the degradation of pollutants, is one of the focal themes on which the Blue Growth aims to. A repertoire of marine-derived bio-products, biomaterials, processes, and services useful for efficient, economic, low impact, treatments for the recovery of oil-polluted areas has been demonstrated in many years of research around the world. Nonetheless, although bioremediation technology is routinely applied in soil, this is not still standardized in the marine environment and the potential market is almost underexploited. This review provides a summary of opportunities for the exploiting and addition of value to research products already validated. Moreover, the review discusses challenges that limit bioremediation in marine environment and actions that can facilitate the conveying of valuable products/processes towards the market.


Subject(s)
Environmental Pollutants , Petroleum Pollution , Petroleum , Water Pollutants, Chemical , Animals , Humans , Biodegradation, Environmental , Petroleum/metabolism , Water Pollutants, Chemical/analysis
2.
Bioresour Technol ; 368: 128287, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36368485

ABSTRACT

The production and disposal of plastics from limited fossil reserves, has prompted research for greener and sustainable alternatives. Polyhydroxyalkanoates (PHAs) are biocompatible, biodegradable, and thermoprocessable polyester produced by microbes. PHAs found several applications but their use is limited due to high production cost and low yields. Herein, for the first time, the isolation and characterization of Pseudohalocynthiibacter aestuariivivens P96, a marine bacterium able to produce surprising amount of PHAs is reported. In the best growth condition P96 was able to reach a maximum production of 4.73 g/L, corresponding to the 87 % of total cell dry-weight. Using scanning and transmission microscopy, lab-scale fermentation, spectroscopic techniques, and genome analysis, the production of thermoprocessable polymer Polyhydroxybutyrate P(3HB), a PHAs class, endowed with mechanical and thermal properties comparable to that of petroleum-based plastics was confirmed. This study represents a milestone toward the use of this unexplored marine bacterium for P(3HB) production.


Subject(s)
Polyhydroxyalkanoates , Rhodobacteraceae , 3-Hydroxybutyric Acid , Polyesters , Plastics
3.
Mar Drugs ; 18(5)2020 May 20.
Article in English | MEDLINE | ID: mdl-32443698

ABSTRACT

Rhamnolipids (RLs) are surface-active molecules mainly produced by Pseudomonas spp. Antarctica is one of the less explored places on Earth and bioprospecting for novel RL producer strains represents a promising strategy for the discovery of novel structures. In the present study, 34 cultivable bacteria isolated from Edmonson Point Lake, Ross Sea, Antarctica were subjected to preliminary screening for the biosurfactant activity. The positive strains were identified by 16S rRNA gene sequencing and the produced RLs were characterized by liquid chromatography coupled to high resolution mass spectrometry (LC-HRESIMS) and liquid chromatography coupled with tandem spectrometry (LC-MS/MS), resulting in a new mixture of 17 different RL congeners, with six previously undescribed RLs. We explored the influence of the carbon source on the RL composition using 12 different raw materials, such as monosaccharides, polysaccharides and petroleum industry derivatives, reporting for the first time the production of RLs using, as sole carbon source, anthracene and benzene. Moreover, we investigated the antimicrobial potential of the RL mixture, towards a panel of both Gram-positive and Gram-negative pathogens, reporting very interesting results towards Listeria monocytogenes with a minimum inhibitory concentration (MIC) value of 3.13 µg/mL. Finally, we report for the first time the antimicrobial activity of RLs towards three strains of the emerging multidrug resistant Stenotrophomonas maltophilia with MIC values of 12.5 µg/ml.


Subject(s)
Anti-Bacterial Agents/pharmacology , Decanoates/pharmacology , Pseudomonas , Rhamnose/analogs & derivatives , Surface-Active Agents/chemistry , Animals , Antarctic Regions , Decanoates/chemistry , Humans , Listeria monocytogenes/drug effects , Microbial Sensitivity Tests , Rhamnose/chemistry , Rhamnose/pharmacology , Stenotrophomonas maltophilia/drug effects
4.
Mar Drugs ; 16(6)2018 May 28.
Article in English | MEDLINE | ID: mdl-29843452

ABSTRACT

The combination of LC-MS/MS based metabolomics approach and anti-MRSA activity-guided fractionation scheme was applied on the Gram-negative bacterium Aequorivita sp. isolated from shallow Antarctic sea sediment using a miniaturized culture chip technique. This methodology afforded the isolation of three new (1⁻3) and four known (4⁻7) N-terminal glycine- or serine-bearing iso-fatty acid amides esterified with another iso-fatty acid through their C-3 hydroxy groups. The chemical structures of the new compounds were elucidated using a set of spectroscopic (NMR, [α]D and FT-IR) and spectrometric (HRMS, HRMS/MS) methods. The aminolipids possessing an N-terminal glycine unit (1, 2, 4, 5) showed moderate in vitro antimicrobial activity against MRSA (IC50 values 22⁻145 µg/mL). This is the first in-depth chemistry and biological activity study performed on the microbial genus Aequorivita.


Subject(s)
Amino Acids/isolation & purification , Anti-Bacterial Agents/isolation & purification , Fatty Acids/isolation & purification , Flavobacteriaceae/metabolism , Amino Acids/chemistry , Amino Acids/pharmacology , Antarctic Regions , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Chemical Fractionation/methods , Fatty Acids/chemistry , Fatty Acids/pharmacology , Geologic Sediments , Metabolomics/methods , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Molecular Structure , Seawater , Sequence Analysis, DNA , Spectroscopy, Fourier Transform Infrared
5.
Mar Biotechnol (NY) ; 20(4): 502-511, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29651633

ABSTRACT

The exploration of poorly studied areas of Earth can highly increase the possibility to discover novel bioactive compounds. In this study, the cultivable fraction of fungi and bacteria from Barents Sea sediments has been studied to mine new bioactive molecules with antibacterial activity against a panel of human pathogens. We isolated diverse strains of psychrophilic and halophilic bacteria and fungi from a collection of nine samples from sea sediment. Following a full bioassay-guided approach, we isolated a new promising polyextremophilic marine fungus strain 8Na, identified as Aspergillus protuberus MUT 3638, possessing the potential to produce antimicrobial agents. This fungus, isolated from cold seawater, was able to grow in a wide range of salinity, pH and temperatures. The growth conditions were optimised and scaled to fermentation, and its produced extract was subjected to chemical analysis. The active component was identified as bisvertinolone, a member of sorbicillonoid family that was found to display significant activity against Staphylococcus aureus with a minimum inhibitory concentration (MIC) of 30 µg/mL.


Subject(s)
Alkenes/pharmacology , Anti-Bacterial Agents/metabolism , Aspergillus/chemistry , Aspergillus/isolation & purification , Cyclohexanones/pharmacology , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/pharmacology , Bacteria/chemistry , Bacteria/isolation & purification , Fungi/chemistry , Fungi/isolation & purification , Geologic Sediments/microbiology , Microbial Sensitivity Tests , Oceans and Seas , Staphylococcus aureus/isolation & purification
6.
Bio Protoc ; 6(20)2016 10 20.
Article in English | MEDLINE | ID: mdl-28255573

ABSTRACT

This protocol describes two biological assays to evaluate pathogenicity of Burkholderia cepacia complex (Bcc) strains against the nematode Caenorhabditis elegans. Specifically, these two assays allow one to identify if the under-investigated Bcc strains are able to kill the nematodes by intestinal colonization (slow killing assay, SKA) or by toxins production (fast killing assay, FKA). The principal differences between the two assays rely on the different killing kinetics for worms.

SELECTION OF CITATIONS
SEARCH DETAIL
...